This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Walgreens is selling itself to the private equity firm Sycamore Partners. This c...
Houston Methodist Coordinate Care is reducing costs through a partnership with K...
A new Flagship Pioneering startup has emerged with $200 million and a team of ex...
BioNTech has forecast lackluster sales for 2025 despite ending last year on a re...
CagriSema, a dual-acting drug in development by Novo Nordisk, met the goal of a ...
Emergent BioSolutions is selling a manufacturing site in Baltimore — which has a...
Compounding pharmacies faced a major setback in their case over the FDA’s decisi...
Emergent is selling a manufacturing site in Baltimore — which has a history of c...
Beam Therapeutics said its experimental gene editing treatment helped lower leve...
At this year’s American Academy of Dermatology annual meeting, companies like Am...
The FDA told staff on Monday that reviewers of medical products and inspectors o...
Novo Nordisk’s late-stage weight loss data showed CagriSema performed below anal...
For the 91st episode of the CIO podcast hosted by Healthcare IT Today, we are jo...
Johnson & Johnson and Protagonist Therapeutics have bet their oral IL-23 drug wi...
Trevi Therapeutics’ chronic cough drug reduced patients’ 24-hour cough frequency...
[Sponsored] Innovative sterilization cases and trays are instrumental in reducin...